@article{article14aa66bf,
title   = {Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I–III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial},
author = {Ismael, Gustavo and Hegg, Roberto and Muehlbauer, Susanne and Heinzmann, Dominik and Lum, Bert and Kim, Sung-Bae and Pienkowski, Tadeusz and Lichinitser, Mikhail and Semiglazov, Vladimir and Melichar, Bohuslav and Jackisch, Christian},
year = {2012},
doi = {10.1016/S1470-2045(12)70329-7},
journal   = {The lancet: oncology}
}